Association of Antiplatelet Therapy With Lower Risk of Death and Recurrent Cerebrovascular Events After Ischemic Stroke: Results From the China Ischemic Stroke Registry Study

Background: Evidence of the beneficial effects of antiplatelet therapy after ischemic stroke is currently lacking in China. Methods and Results: Demographic data, pre-stroke risk factors, severity of neurological deficit, and disability graded by the National Institutes of Health Stroke Scale (NIHSS...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Circulation Journal 2009, Vol.73(12), pp.2342-2347
Hauptverfasser:	Ding, Ding, Lu, Chuan-Zhen, Fu, Jian-Hui, Hong, Zhen, The China Ischemic Stroke Registry Study (CISRS) investigators
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged All-cause mortality Antiplatelet therapy Asian Continental Ancestry Group - statistics & numerical data Brain Ischemia - complications Brain Ischemia - drug therapy Brain Ischemia - ethnology Brain Ischemia - mortality Cause of Death Cerebrovascular events China China - epidemiology Disability Evaluation Female Humans Ischemic stroke Kaplan-Meier Estimate Male Middle Aged Platelet Aggregation Inhibitors - therapeutic use Proportional Hazards Models Prospective Studies Registries Risk Assessment Risk Factors Secondary Prevention Severity of Illness Index Stroke - drug therapy Stroke - ethnology Stroke - etiology Stroke - mortality Time Factors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!